Arterial Remodeling Technologies to Disclose for the First Time the Novel Design, and New Data, for its Potentially Disruptive Polymer-based Bioresorbable Stent
5/17/2011 10:16:03 AM
PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) announced today that details of the state-of-the-art design of its potentially disruptive polymer-based bioresorbable stent platform will be revealed, for the first time, at EuroPCR 2011 from the podium tomorrow (Wednesday, May 18). The disclosure will be presented by Antoine LaFont, M.D., Ph.D., Professor of Medicine, Head Interventional Cardiology Department, Georges Pompidou Hospital (Paris); and, Past Chairman, Interventional Cardiology Group, European Society of Cardiology (ESC). Dr. LaFont is a co-founder of ART.
comments powered by